I've never said it's not eligible. The big question mark is on what basis will it be approved, given that the data must be deemed "necessary" which is a huge question mark still.
If they released the expert report to the market it would clear up a lot imo
There is still then the matter of why would a doctor prescribe it unless they can demonstrate success and efficacy after launch in Australia, which is still yet to be seen.
I've never said it's not eligible. The big question mark is on...
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $72.29M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 122878 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 35106 | 2 |
View Market Depth
| Last trade - 10.19am 14/10/2024 (20 minute delay) ? |
| RSH (ASX) Chart |
Day chart unavailable